The study hypothesis is that prophylactic fibrinogen infusion reduces postoperative bleeding
and transfusion requirements after coronary artery bypass surgery (CABG) in patients with
endogenous fibrinogen levels in the lower normal range. 60 patients will be included in a
prospective, randomized double-blind placebo-controlled single center study.